Skip to content
naulon

Retracted on Dec 31, 2025. Do not cite it as support.

Source: Retraction Watch, via Crossref · checked Nov 3, 2026 · Read the notice

  • Corrected on May 15, 2018. Source: Retraction Watch, via Crossref · Read the notice

MiR-124 acts as a target for Alzheimer’s disease by regulating BACE1

Fengmao An, Guohua Gong, Yu Wang and 3 more

Oncotarget · 2017

doi:10.18632/oncotarget.23119

Abstract

// Fengmao An 1, 2, * , Guohua Gong 1, 2, 3, * , Yu Wang 1, 2 , Ming Bian 1, 2 , Lijun Yu 1, 2 and Chengxi Wei 1, 2 1 Medicinal Chemistry and Pharmacology Institute, Inner Mongolia University for The Nationalities, Tongliao, Inner Mongolia, P.R. China 2 Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, Inner Mongolia, P.R. China 3 First Clinical Medical of Inner Mongolia University for Nationalities, Tongliao, Inner Mongolia, P.R. China * These authors have contributed equally to this work Correspondence to: Chengxi Wei, email: weichengxi1224@163.com Lijun Yu, email: tl_ylj@163.com Keywords: Alzheimer’s disease; miR-124; BACE1; cell viability; cell apoptosis Received: June 03, 2017 Accepted: November 03, 2017 Published: December 09, 2017 ABSTRACT Although large numbers of microRNAs (miRNAs) expressed in Alzheimer disease (AD) have been detected, their functions and mechanisms of regulation remain to be fully clarified. Beta-site Amyloid precursor protein Cleaving Enzyme 1 (BACE1) has been one of the prime therapeutic targets for AD. Here, we identified that miR-124 levels are gradually decreased in AD. In addition, we demonstrated that miR-124 suppresses BACE1 expression by directly targeting the 3′UTR of Bace1 mRNA in vitro . Inhibition of miR-124 significantly increased BACE1 levels in neuronal cells. In contrast, miR-124 overexpression significantly suppressed BACE1 expression in cells. And finally we determined that downregulation of miR-124 alleviated Aβ-induced viability inhibition and decreased apoptosis in SH-SY5Y cells. Our results demonstrated that miR-124 is a potent negative regulator of BACE1 in the cellular AD phenotype and might be involved in the pathogenesis of AD.

Full text

We don’t show the text of a retracted or withdrawn paper. The record stays, so citations to it can be checked.

Cited by papers we hold 1

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.